<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" bill-type="olc" dms-id="H4822B57A37D148D69F6E2BEFA6A53F77" public-private="public">
	<form>
		<distribution-code display="yes">I</distribution-code>
		<congress>114th CONGRESS</congress>
		<session>1st Session</session>
		<legis-num>H. R. 3520</legis-num>
		<current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber>
		<action>
			<action-date date="20150916">September 16, 2015</action-date>
			<action-desc><sponsor name-id="B000755">Mr. Brady of Texas</sponsor> (for himself and <cosponsor name-id="C001036">Mrs. Capps</cosponsor>) introduced the following bill; which was referred to the <committee-name committee-id="HIF00">Committee on Energy and Commerce</committee-name></action-desc>
		</action>
		<legis-type>A BILL</legis-type>
		<official-title>To amend the Public Health Service Act to establish an interagency coordinating committee on
			 pulmonary hypertension, and for other purposes.</official-title>
	</form>
	<legis-body id="H30FDD3DBD8AB4C8CBBDC12C5A91AD54F" style="OLC">
		<section id="HA58DE97E56654AEFA0C2855CE18A9331" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote>Pulmonary Hypertension Research and Diagnosis Act of 2015</quote>.</text>
		</section><section id="H5E3630C3FE304629B4F7A5B368E5C670"><enum>2.</enum><header>Interagency pulmonary hypertension coordinating committee established</header><text display-inline="no-display-inline">Part P of title III of the Public Health Service Act (42 U.S.C. 280g et seq.) is amended by adding
			 at the end the following new section:</text>
			<quoted-block id="H522798710D1E4C3BA9B549E6F8AB0C98">
				<section id="H1BB5F6730C444701871C8A14AE666CFD"><enum>399V–6.</enum><header>Interagency Pulmonary Hypertension Coordinating Committee</header>
					<subsection id="H45AB874FD8BC48AA950019DEC10F9559"><enum>(a)</enum><header>Committee established</header><text display-inline="yes-display-inline">The Secretary shall establish a committee, to be known as the Interagency Pulmonary Hypertension
			 Coordinating Committee (in this section referred to as the <quote>Committee</quote>), to coordinate all efforts within the Department of Health and Human Services concerning
			 pulmonary hypertension.</text>
					</subsection><subsection id="HB853E57451894EB39C56DCA55ADEC2D1"><enum>(b)</enum><header>Responsibilities</header><text>The Committee shall—</text>
						<paragraph id="HA95B1D437F4C4EC9AE0ED66AFE6E6CB4"><enum>(1)</enum><text>develop and annually update a summary of the advances made in research on, and treatment and
			 diagnosis of, pulmonary hypertension;</text>
						</paragraph><paragraph id="H41292B74F45E4FF3942B03E057522596"><enum>(2)</enum><text>develop and annually update a summary of the advances made in access to care for individuals with a
			 diagnosis of pulmonary hypertension;</text>
						</paragraph><paragraph id="HA7ED7FF2E53245A4BED4845C277C702E"><enum>(3)</enum><text display-inline="yes-display-inline">monitor pulmonary hypertension research, services, and support activities across the Federal
			 Government, including coordination of Federal activities and programs with
			 respect to pulmonary hypertension;</text>
						</paragraph><paragraph id="H53F86DF0A65F4A738A1CA7B73362A5D1"><enum>(4)</enum><text>develop and annually update a comprehensive strategic plan under subsection (c) to improve health
			 outcomes for individuals with a diagnosis of pulmonary hypertension; and</text>
						</paragraph><paragraph id="HF84D561523694A26BA742D1948E14B6F"><enum>(5)</enum><text>develop and annually update the progress made in implementing such comprehensive strategic plan.</text>
						</paragraph></subsection><subsection id="HB33C2A4F4A2D44A8ADB335A60741A5A9"><enum>(c)</enum><header>Strategy</header><text display-inline="yes-display-inline">Not later than one year after the date of the enactment of the Pulmonary Hypertension Research and
			 Diagnosis Act of 2015 and annually thereafter, the Committee shall submit
			 to Congress and the Secretary a strategy to improve health outcomes for
			 individuals with a diagnosis of pulmonary hypertension. Such strategy
			 shall include the following:</text>
						<paragraph id="H73D3E7DF65514322BA7AF4C071D36109"><enum>(1)</enum><text>Recommendations to advance research on pulmonary hypertension.</text>
						</paragraph><paragraph id="HE68D23F705DC49CE93B0E7475B73FEA0"><enum>(2)</enum><text>Recommendations to improve the transplantation criteria and process concerning lung and heart-lung
			 transplants for individuals with a diagnosis of pulmonary hypertension.</text>
						</paragraph><paragraph id="H8D9CF0CA5AB447A7B2539407B0F2811B"><enum>(3)</enum><text>Recommendations to improve public awareness and recognition of pulmonary hypertension.</text>
						</paragraph><paragraph id="HB678C2FA4F9A49A0914B1AD3F123C5AE"><enum>(4)</enum><text>Recommendations to improve health care delivery for individuals with a diagnosis of pulmonary
			 hypertension.</text>
						</paragraph><paragraph id="HCF2AA0E7B8CD4966AE3DF5C97556E814"><enum>(5)</enum><text display-inline="yes-display-inline">Recommendations to improve the early and accurate diagnosis of pulmonary hypertension.</text>
						</paragraph><paragraph commented="no" id="HFC8927F2B20D490294382EEC9FE35F6E"><enum>(6)</enum><text display-inline="yes-display-inline">Recommendations to systematically advance the full spectrum of biomedical research on pulmonary
			 hypertension.</text>
						</paragraph></subsection><subsection id="H2CD1696656A947AE93E13C72895A2A9D"><enum>(d)</enum><header>Membership</header>
						<paragraph id="HA9BE347E3FE5424896B7BAD0A79E210C"><enum>(1)</enum><header>In general</header><text>The Committee shall be composed of—</text>
							<subparagraph id="H7CF14CBE451446F5A70DADEF29569791"><enum>(A)</enum><text>a representative from each of the entities listed in paragraph (2); and</text>
							</subparagraph><subparagraph id="H558C7E3524D9489B8132AD53A265D680"><enum>(B)</enum><text>the non-Federal members appointed under paragraph (3).</text>
							</subparagraph></paragraph><paragraph id="H0C299E0BCD604E72BB8A43187A271F73"><enum>(2)</enum><header>Federal members</header><text>The entities listed in this paragraph are the following:</text>
							<subparagraph commented="no" id="HBD358D4E9C5D47ABB55F0C46569E90C5"><enum>(A)</enum><text display-inline="yes-display-inline">The Department of Defense.</text>
							</subparagraph><subparagraph commented="no" id="HC441B8FAA9D54A37AF6548AF7A2B5BAA"><enum>(B)</enum><text>The Food and Drug Administration.</text>
							</subparagraph><subparagraph id="H0CCDF384183E41D2A327DD1CE2FFCB10"><enum>(C)</enum><text>The National Institutes of Health.</text>
							</subparagraph><subparagraph id="HFAE18D665CA54D6A8A7D720ACC5D0018"><enum>(D)</enum><text>The Agency for Healthcare Research and Quality.</text>
							</subparagraph><subparagraph commented="no" id="H198FC0DCE5044A9389801138C967EDFF"><enum>(E)</enum><text>The Administration for Children and Families.</text>
							</subparagraph><subparagraph commented="no" id="HE0EB1E0D906D4801B769E41805609FCF"><enum>(F)</enum><text>The Centers for Disease Control and Prevention.</text>
							</subparagraph><subparagraph commented="no" id="H669AAB553D0848F58991CD8BC1C81671"><enum>(G)</enum><text>The Centers for Medicare &amp; Medicaid Services.</text>
							</subparagraph><subparagraph commented="no" id="H616FE04D43694E37867871E56FF31BB0"><enum>(H)</enum><text>The Health Resources and Services Administration.</text>
							</subparagraph></paragraph><paragraph id="H59B883EA234C4B66921C2892DFDDB2B1"><enum>(3)</enum><header>Non-Federal members</header><text>Not fewer than six members of the Committee or one-third of the total membership of the Committee,
			 whichever is greater, shall be composed of non-Federal members to be
			 appointed by the Secretary, of which—</text>
							<subparagraph id="HD58E25EF9A6F4366842D4AA445B641A0"><enum>(A)</enum><text>at least two shall be individuals with a diagnosis of pulmonary hypertension;</text>
							</subparagraph><subparagraph id="HF49A5DAF2B8E4AAE9824BE471FCC5242"><enum>(B)</enum><text>at least one shall be the parent or guardian of an individual with a diagnosis of pulmonary
			 hypertension;</text>
							</subparagraph><subparagraph commented="no" id="HEE9B094A8E1D4FB18A336DE7B6E63BCA"><enum>(C)</enum><text>at least one shall be a representative of a pharmaceutical company that manufactures a drug or
			 device for detecting, preventing, or treating pulmonary hypertension; and</text>
							</subparagraph><subparagraph id="H8BD142C8404640BABAD146EBC00CE1BF"><enum>(D)</enum><text>at least one shall be a representative of a leading research, advocacy, or support organization
			 primarily serving individuals with a diagnosis of pulmonary hypertension.</text>
							</subparagraph></paragraph></subsection><subsection commented="no" id="H278B8AFEE62D456989A97B72A0961D62"><enum>(e)</enum><header>Meetings</header><text>The Committee shall meet not fewer than two times each year. All meetings shall be open to the
			 public.</text>
					</subsection><subsection commented="no" id="H183FF47AF9D04EF791A5B376BA61E350"><enum>(f)</enum><header>Termination date</header><text display-inline="yes-display-inline">The Committee shall terminate on the date that is five years after the date of the enactment of the
			 Pulmonary Hypertension Research and Diagnosis Act of 2015.</text></subsection></section><after-quoted-block>.</after-quoted-block></quoted-block>
		</section><section id="H31AF192A8DBE44B09D3827FA35948867"><enum>3.</enum><header>Report to Congress</header>
			<subsection id="H932EF83DD2FA41299FA21628208FE572"><enum>(a)</enum><header>Report required</header><text>Not later than two years after the date of the enactment of this Act, the Secretary of Health and
			 Human Services, in coordination with the Interagency Pulmonary
			 Hypertension Coordinating Committee, shall prepare and submit to the
			 Committee on Health, Education, Labor, and Pensions of the Senate and the
			 Committee on Energy and Commerce of the House of Representatives a
			 progress report on activities related to improving health outcomes for
			 individuals with a diagnosis of pulmonary hypertension.</text>
			</subsection><subsection id="H0866A8B537144033BE98803B4B0F4B51"><enum>(b)</enum><header>Contents of report</header><text>The report submitted under subsection (a) shall contain—</text>
				<paragraph id="HDE5AA550440242489457CF1DDE2966C0"><enum>(1)</enum><text display-inline="yes-display-inline">information on the incidence of pulmonary hypertension, including such incidence since the date of
			 the enactment of this Act;</text>
				</paragraph><paragraph id="H3E8D0EE21AD8492F990182F6BEFBAFBC"><enum>(2)</enum><text>information on the prevalence of pulmonary hypertension in children and adults;</text>
				</paragraph><paragraph id="H4C8787D88F7A4127834796F15F7D79A4"><enum>(3)</enum><text>information on the average time between the initial screening and the accurate diagnosis of
			 pulmonary hypertension;</text>
				</paragraph><paragraph id="HDC46550887EF4DABBFA16ADF4B6819E0"><enum>(4)</enum><text>information on the average stage of pulmonary hypertension when appropriate intervention begins;</text>
				</paragraph><paragraph id="HE8172AB686894254A1AC13DD4EF71765"><enum>(5)</enum><text>information on the effectiveness and outcomes of interventions for individuals with a diagnosis of
			 pulmonary hypertension, including—</text>
					<subparagraph id="H57C501BF1C2A4CE38F3C817BCDA6213A"><enum>(A)</enum><text>mortality rate; and</text>
					</subparagraph><subparagraph id="H43FAF9DAA19343CABC462BF6C38E80C3"><enum>(B)</enum><text>the frequency of drastic treatment options such as lung and heart-lung transplants;</text>
					</subparagraph></paragraph><paragraph id="H520EE241FE414F3B827449E141D33EC0"><enum>(6)</enum><text>information on new developments in research activities;</text>
				</paragraph><paragraph id="H331C47A081C74CBE8B04EF938C4C051A"><enum>(7)</enum><text>information on innovative treatment options and diagnostic tools; and</text>
				</paragraph><paragraph id="HE2F312B082F8419B8F591AFBB332B4F7"><enum>(8)</enum><text>information on services and supports available to individuals with a diagnosis of pulmonary
			 hypertension.</text>
				</paragraph></subsection><subsection id="H8921DC2791FE4264971031D93AF4E9A2"><enum>(c)</enum><header>Publication</header><text>The Secretary of Health and Human Services shall make the report submitted under subsection (a)
			 available on the public website of the Department of Health and Human
			 Services.</text>
			</subsection></section></legis-body>
</bill>
